BioMedNewsBreaks – LexaGene Holdings Inc. (TSX.V: LXG) (OTCQB: LXXGF) Announces Participation in Two Upcoming Virtual Events

LexaGene Holdings (TSX.V: LXG) (OTCQB: LXXGF), a molecular diagnostics company that develops fully automated rapid pathogen detection systems, will be presenting at two investor conferences in January: the SNN Network Canada Virtual Event and the H.C. Wainwright Bioconnect 2021 Virtual Conference. Company founder and CEO Dr. Jack Regan will represent LexaGene at both events. The SNN Network Canada Virtual Event is scheduled for Thursday, Jan. 7, 2021; LexaGene’s live presentation is slated to begin at 1:30 p.m. ET. Those interested can find the webcast presentation on the conference event platform under the agenda tab following the event. The H.C. Wainwright Bioconnect 2021 Virtual Conference is scheduled for Jan. 11–14, 2021. Conference content, including LexaGene’s presentation, is available on demand.

To view LexaGene’s live SNN Network Canada presentation, visit https://ibn.fm/ljcnO

To view LexaGene’s H.C. Wainwright Bioconnect 2021 Virtual Conference presentation, visit https://ibn.fm/SBy82

To view the full press release, visit https://ibn.fm/Vrxac

About LexaGene Holdings Inc. 

LexaGene is a molecular diagnostics company that develops molecular diagnostic systems for pathogen detection and genetic testing for other molecular markers for onsite rapid testing in veterinary diagnostics and food safety, and for use in open-access markets such as clinical research, agricultural testing and biodefense. End users simply need to collect a sample, load the sample onto the instrument with a sample preparation cartridge, enter the sample ID and press go. The MiQLab system delivers excellent sensitivity, specificity and breadth of detection, and can return results in approximately one hour. The unique open-access feature is designed for custom testing so that end users can load their own real-time PCR assays onto the instrument to target any genetic target of interest. For more information about the company, visit www.LexaGene.com.

NOTE TO INVESTORS: The latest news and updates relating to LXXGF are available in the company’s newsroom at https://ibn.fm/LXXGF

About BioMedWire

BioMedWire (BMW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) BioMedNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. BMW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled visibility, recognition and brand awareness. BMW is where news, content and information converge.

To receive SMS text alerts from BioMedWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)

For more information please visit https://www.biomedwire.com

Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: http://BMW.fm/Disclaimer

BioMedWire (BMW)
San Francisco, California
www.biomedwire.com
415.949.5050 Office
Editor@BioMedWire.com

BioMedWire is part of the InvestorBrandNetwork